Molina Healthcare 2026 Forecast: Costs Surge, Profits Crash

Sponsored by Lake Region State College
Train for the jobs AI can’t take—yet.

Molina Healthcare’s latest results confirm what analysts feared all quarter: the Medicaid-focused insurer is entering one of the most difficult operating environments in a decade. A rare quarterly loss, collapsing guidance, and industry-wide cost inflation have officially shaken investor confidence in Molina Healthcare’s 2026 forecast — and the entire government-backed insurance ecosystem.

This is the fully accurate, SEO-optimized, and investor-ready breakdown of what happened and what it means for the stock.

Molina Healthcare 2026 Forecast: A Quarter That Triggered Market Alarm

A Rare and Severe Quarterly Loss

For Q4 2025, Molina reported:

Adjusted EPS: –$2.75, missing expectations of +$0.43
A collapse from $5.05 one year prior
Revenues up 8.3% to $11.4 billion, beating estimates

Revenue wasn’t the problem — costs were.

Membership Declines Where It Matters Most

As of December 31, 2025:

Total membership fell to ~5.49 million (–0.8%)
Missed estimates
Marketplace and Medicare enrollment grew
Medicaid, the core profit engine, declined

Medicaid membership loss is especially problematic because the business depends on stable capitation payments and predictable claim behavior.

Expenses Surged — Fast

Operating expenses rose 14% year over year, driven by:

Higher medical care costs
Increased administrative expenses
Elevated premium taxes
Interest expense up 52.9%

And the most painful number:

Medical Care Ratio (MCR) surged to 94.6%, up 440 bps.
For a Medicaid-heavy insurer, that’s a margin crusher.

Why Molina Healthcare’s 2026 Guidance Sent the Stock Crashing

A Stunning Cut to Profit Expectations

Molina now forecasts:

2026 adjusted EPS: at least $5.00
Street expectations: $13.76

A more than 60% miss.

This is not a tweak — it’s a signal that 2026 will be structurally difficult.

The CEO’s Warning Was Blunt

CEO Joseph Zubretsky called 2026:

“A trough year for Medicaid industry margins.”

Translation:
Costs are rising faster than states are increasing reimbursement — and the math no longer works.

Exit from Medicare Advantage Part D

Molina announced it will exit its Medicare Advantage Part D business in 2027, walking away from $1 billion in annual premiums.

The failure of this line alone cut $1 per share from the 2026 outlook.

Florida Medicaid Contract Will Hurt 2026 Earnings

The rollout of a new Florida contract is expected to reduce 2026 EPS by an additional $1.50 per share.

New Medicaid contracts typically start margin-negative — but starting one in the middle of inflationary pressure creates outsized financial drag.

Industry Context: Molina Isn’t Alone, But It’s Under More Pressure

The challenges facing Molina reflect broader stress across government-funded plans:

ACA Marketplace Plans Are Mispriced Across the Industry

Peers have echoed similar concerns:

Elevance Health reported higher ACA costs
Centene and Oscar Health declined as investor concern spread
Cigna and UnitedHealth saw related volatility

Marketplace risk pools are sicker and more complex than pricing assumptions anticipated.

Medicare Advantage Is Also Volatile

Across the sector:

UnitedHealth is resetting expectations
Humana declined after withholding 2026 commentary
Lower star ratings and rising pharmacy costs tighten margins

The entire government-subsidized insurance ecosystem is dealing with elevated utilization and lagging reimbursements.

Why Molina Healthcare Is Getting Hit Harder Than Peers

Molina is uniquely sensitive because:

Its mix is overwhelmingly Medicaid, which offers the lowest margin of the three government categories (Medicaid, Medicare Advantage, ACA).
Medicaid rate adjustments lag cost inflation by 12–18 months.
Behavioral health, pharmacy, and chronic care utilization are running hotter than expected.
Redeterminations created increased acuity in remaining membership.

When costs accelerate, Medicaid-only insurers have fewer levers to offset the pressure.

What Molina Healthcare’s 2026 Forecast Means for the Stock

Short-Term: High Volatility, Limited Visibility

Investors now face:

Missed earnings
Shrinking Medicaid membership
An expensive Florida ramp
A full exit from Part D
Elevated MCR with no quick fix

Molina shares reacted sharply — and the volatility will likely continue until costs stabilize.

Medium-Term: Depends Entirely on State Rate Relief

If states aggressively increase Medicaid reimbursement rates, margins can recover.
If not, Molina could experience a multi-year earnings reset.

Long-Term: Still a Viable Company — With a Different Margin Profile

Molina’s long-term model remains intact, but the high-teens EPS trajectory of prior years is gone for now.

Expect:

Lower peak margins
More conservative guidance
Higher sensitivity to utilization trends
Greater scrutiny from investors

This is no longer the stable Medicaid pure-play of 2018–2023.

The Bigger Story: Molina Is the First Domino

Molina’s guidance cut highlights a deeper truth:

Government-backed plans are underpriced for post-pandemic utilization
Medicaid rates have lagged inflation
ACA Marketplace members are sicker than expected
Medicare Advantage pharmacy costs remain elevated
Utilization across all government lines is structurally higher

Molina isn’t failing.
The government-insurance business model is being stress-tested in real time.

And 2026 is officially the trough year.

Disclaimer

This article is for informational and educational purposes only. It is not investment advice, financial advice, or a recommendation to buy or sell any security, including Molina Healthcare (MOH), Centene (CNC), UnitedHealth Group (UNH), Elevance Health (ELV), Cigna (CI), Oscar Health (OSCR), or Humana (HUM). Always conduct your own research or consult a professional before making financial decisions.

MACROHINT

MACROHINT

Molina Healthcare 2026 Forecast: Costs Surge, Profits Crash